샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777517

세계의 호흡기세포융합바이러스 진단 시장

Respiratory Syncytial Virus Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 292 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

호흡기세포융합바이러스 진단 세계 시장은 2030년까지 77억 달러에 달할 전망

2024년에 61억 달러로 추정되는 호흡기세포융합바이러스 진단 세계 시장은 2024년부터 2030년까지 CAGR 4.0%로 성장하여 2030년에는 77억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 직접 형광 항체법은 CAGR 3.1%를 기록하며 분석 기간 종료까지 19억 달러에 달할 것으로 예측됩니다. 신속 항원 진단 검사 분야의 성장률은 분석 기간 동안 CAGR 3.1%로 추정됩니다.

미국 시장은 17억 달러로 추정, 중국은 CAGR 7.2%로 성장 예측

미국의 호흡기세포융합바이러스 진단 시장은 2024년에 17억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 15억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 7.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.7%와 3.0%로 예측됩니다. 유럽에서는 독일이 CAGR 2.3%로 성장할 것으로 예측됩니다.

세계 호흡기세포융합바이러스 진단 시장 - 주요 동향 및 촉진요인 정리

호흡기세포융합바이러스(RSV)의 조기 및 정확한 진단이 그 어느 때보다 중요한 이유는 무엇일까?

호흡기세포융합바이러스(RSV)는 전염성이 강한 바이러스로 특히 영유아, 노인, 면역력이 약한 사람에게 심각한 호흡기 감염을 일으킵니다. RSV는 여전히 영유아의 주요 입원 원인이며, 노인의 경우 심각한 이환율의 원인으로 작용하고 있어 신속하고 정확한 진단약에 대한 수요가 급증하고 있습니다. RSV 감염의 계절성은 독감이나 COVID-19와 같은 다른 호흡기질환을 모방하는 능력과 함께 RSV와 다른 바이러스 병원체를 구별할 수 있는 고급 진단 도구의 필요성을 강조하고 있습니다. 또한, 최근 RSV의 집단 발생과 다른 호흡기 바이러스와의 병발이 나타나면서 신뢰할 수 있는 진단 솔루션의 필요성이 더욱 커지고 있습니다. 정부, 의료 기관, 진단 기업들은 조기 개입을 촉진하고, 감염률을 낮추며, 환자 결과를 개선하기 위해 RSV 탐지 기술에 많은 투자를 하고 있습니다.

RSV 진단 기술의 혁신은 어떻게 검출과 정확도를 높이고 있는가?

RSV 진단의 상황은 분자검사, 현장진단, AI를 활용한 진단 플랫폼의 등장으로 크게 진화하고 있습니다. 바이러스 배양이나 직접 형광 항체(DFA) 검사 등의 전통적인 방법은 보다 민감하고 빠른 분자 분석으로 대체되고 있습니다. 중합효소 연쇄 반응(PCR) 기반 진단법은 RSV 검출의 황금 표준으로 등장했으며, 높은 정확도와 낮은 바이러스 양으로도 검출할 수 있는 능력을 제공합니다. 또한, 루프 매개 등온증폭(LAMP)과 같은 등온증폭 기술의 개발로 특히 자원이 한정된 환경에서 신속하고 비용 효율적인 RSV 진단이 용이해졌습니다. 영상 진단 및 디지털 병리 진단에서 AI와 기계 학습의 통합은 검사 해석을 더욱 개선하고 진단 정확도를 높이며 위음성을 최소화하고 있습니다. RSV 검사 기능이 발전함에 따라 의료 서비스 제공자는 감염을 조기에 발견하고 적절한 치료 전략을 시행할 수 있는 능력이 향상됩니다.

RSV 진단 수요를 견인하는 시장 동향은?

RSV 관련 합병증에 대한 인식의 증가와 현장진단 검사(POCT)의 보급이 시장 확대에 크게 기여하고 있습니다. COVID-19 팬데믹은 RSV, 인플루엔자, SARS-CoV-2를 동시에 검사하여 종합적인 호흡기질환 관리를 가능하게 하는 멀티플렉스 호흡기 바이러스 패널에 대한 관심을 더욱 가속화시키고 있습니다. 또한, 노인 인구에서 RSV 감염의 유병률이 증가함에 따라 장기 요양 시설과 병원에서 일상적인 RSV 스크리닝의 필요성이 증가하고 있습니다. 또한 자가진단 키트와 모바일 진단 플랫폼을 통해 기존 헬스케어 환경 밖에서도 간편하게 RSV를 검출할 수 있어 재택검사와 분산형 검사 솔루션의 확대도 견인차 역할을 하고 있습니다. 또한, RSV 감시 프로그램을 추진하는 정부 이니셔티브와 국가 예방접종 전략에 RSV 진단법을 통합하는 것이 시장 성장을 촉진할 것으로 예상됩니다. 신속하고 신뢰할 수 있는 호흡기 바이러스 검사에 대한 소비자의 수요가 증가함에 따라, 진단약 제조업체들은 검사 편의성과 성능을 향상시키기 위해 지속적인 기술 혁신을 진행하고 있습니다.

호흡기세포융합바이러스 진단 시장의 주요 성장 촉진요인은?

세계 호흡기세포융합바이러스 진단 시장의 성장은 RSV 감염률 증가, 분자진단의 발전, 현장 진료 및 가정 기반 검사 솔루션에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 여러 호흡기 병원체를 동시에 검출할 수 있는 멀티플렉스 검사 패널의 확대는 시장 수요를 더욱 촉진하고 있습니다. 또한, AI 기반 진단 도구와 디지털 병리 플랫폼의 채택이 확대되면서 검사의 정확성과 효율성이 향상되고 있습니다. 또한 RSV 감시 프로그램에 대한 투자 증가와 질병 모니터링 개선을 위한 정부 주도의 노력도 시장 확대에 기여하고 있습니다. 또한, RSV 백신 및 항바이러스 치료제의 개발이 진행됨에 따라 보완적인 진단 솔루션에 대한 수요도 증가할 것으로 예상됩니다. 헬스케어 산업이 감염병 관리를 최우선 과제로 삼고 있는 가운데, RSV 진단 시장은 조기 발견, 질병 예방, 환자 결과 개선을 위한 혁신적인 솔루션을 제공함으로써 지속적인 성장세를 이어갈 준비가 되어 있습니다.

부문

제품(직접 형광 항체법, 신속 항원 진단 검사, 분자진단, 크로마토그래피 면역측정, 영상 진단, 겔 마이크로 드롭렛, 유세포 분석, 기타), 업계별(병원, 연구소, 진료소, 재택의료)

조사 대상 기업 사례

  • Abbott Laboratories
  • Affymetrix(part of Thermo Fisher)
  • Alere Inc.
  • Becton, Dickinson and Company(BD)
  • Biocartis NV
  • BioMerieux Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Cepheid
  • Coris BioConcept
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Fast-track Diagnostics
  • GenMark Diagnostics
  • Grifols S.A.
  • Hologic Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • MilliporeSigma

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.05

Global Respiratory Syncytial Virus Diagnostics Market to Reach US$7.7 Billion by 2030

The global market for Respiratory Syncytial Virus Diagnostics estimated at US$6.1 Billion in the year 2024, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Direct Fluorescent Antibody Method, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Rapid Antigen Diagnostic Test segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 7.2% CAGR

The Respiratory Syncytial Virus Diagnostics market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Respiratory Syncytial Virus Diagnostics Market - Key Trends & Drivers Summarized

Why Is Early and Accurate Diagnosis of Respiratory Syncytial Virus (RSV) More Critical Than Ever?

Respiratory Syncytial Virus (RSV) is a highly contagious virus that causes severe respiratory infections, particularly in infants, the elderly, and immunocompromised individuals. As RSV remains a leading cause of hospitalizations in young children and contributes to significant morbidity in older adults, the demand for rapid and accurate diagnostics has surged. The seasonal nature of RSV infections, coupled with its ability to mimic other respiratory illnesses such as influenza and COVID-19, underscores the need for advanced diagnostic tools that can differentiate RSV from other viral pathogens. Moreover, the recent emergence of RSV outbreaks and co-infections with other respiratory viruses has further increased the urgency for reliable diagnostic solutions. Governments, healthcare institutions, and diagnostic companies are investing heavily in RSV detection technologies to facilitate early intervention, reduce transmission rates, and improve patient outcomes.

How Are Innovations in RSV Diagnostic Technologies Enhancing Detection and Accuracy?

The landscape of RSV diagnostics has evolved significantly with the advent of molecular testing, point-of-care diagnostics, and AI-powered diagnostic platforms. Traditional methods such as viral culture and direct fluorescent antibody (DFA) testing are being phased out in favor of more sensitive and rapid molecular assays. Polymerase chain reaction (PCR)-based diagnostics have emerged as the gold standard for RSV detection, offering high accuracy and the ability to detect even low viral loads. Additionally, the development of isothermal amplification techniques, such as loop-mediated isothermal amplification (LAMP), has facilitated rapid and cost-effective RSV diagnosis, particularly in resource-limited settings. The integration of AI and machine learning in diagnostic imaging and digital pathology is further improving test interpretation, enhancing diagnostic precision, and minimizing false negatives. As RSV testing capabilities advance, healthcare providers are better equipped to detect infections early and implement appropriate treatment strategies.

What Market Trends Are Driving the Demand for RSV Diagnostics?

The growing awareness of RSV-related complications and the increasing adoption of point-of-care testing (POCT) have significantly contributed to market expansion. The COVID-19 pandemic has further accelerated interest in multiplex respiratory virus panels, which simultaneously test for RSV, influenza, and SARS-CoV-2, enabling comprehensive respiratory disease management. Additionally, the rising prevalence of RSV infections in aging populations has increased the need for routine RSV screening in long-term care facilities and hospitals. The expansion of home-based and decentralized testing solutions has also gained traction, with self-testing kits and mobile diagnostic platforms allowing for convenient RSV detection outside traditional healthcare settings. Furthermore, government initiatives promoting RSV surveillance programs and the integration of RSV diagnostics into national immunization strategies are expected to boost market growth. As consumer demand for fast and reliable respiratory virus testing rises, diagnostic manufacturers are continuously innovating to improve test accessibility and performance.

What Are the Key Growth Drivers of the Respiratory Syncytial Virus Diagnostics Market?

The growth in the global respiratory syncytial virus diagnostics market is driven by several factors, including the increasing incidence of RSV infections, advancements in molecular diagnostics, and the rising demand for point-of-care and home-based testing solutions. The expansion of multiplex testing panels, which enable simultaneous detection of multiple respiratory pathogens, has further fueled market demand. Additionally, the growing adoption of AI-driven diagnostic tools and digital pathology platforms is enhancing test accuracy and efficiency. The rising investment in RSV surveillance programs and government-led initiatives to improve disease monitoring are also contributing to market expansion. Furthermore, the ongoing development of RSV vaccines and antiviral treatments is expected to drive demand for complementary diagnostic solutions. As the healthcare industry continues to prioritize infectious disease management, the RSV diagnostics market is poised for sustained growth, offering innovative solutions for early detection, disease prevention, and improved patient outcomes.

SCOPE OF STUDY:

The report analyzes the Respiratory Syncytial Virus Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Others); Vertical (Hospitals, Laboratory, Clinics, Homecare)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Abbott Laboratories
  • Affymetrix (part of Thermo Fisher)
  • Alere Inc.
  • Becton, Dickinson and Company (BD)
  • Biocartis NV
  • BioMerieux Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Cepheid
  • Coris BioConcept
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Fast-track Diagnostics
  • GenMark Diagnostics
  • Grifols S.A.
  • Hologic Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • MilliporeSigma

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Respiratory Syncytial Virus Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of RSV Infections Among Infants and Elderly Populations Drives Diagnostic Demand
    • Expansion of Hospital-Based Respiratory Surveillance Programs Throws the Spotlight on Rapid RSV Testing
    • Increased Adoption of Multiplex Molecular Panels Enhances Detection Accuracy for Co-Infections Including RSV
    • Growth in Point-of-Care Diagnostics Strengthens Business Case for CLIA-Waived RSV Test Kits
    • Regulatory Approvals for Molecular and Antigen-Based RSV Tests Expand Diagnostic Options
    • Technological Advancements in Isothermal Amplification and PCR Accelerate Time-to-Result for RSV Detection
    • Rise in Pediatric Outpatient Visits During Seasonal Peaks Spurs Demand for Rapid Lateral Flow Assays
    • Public Health Surveillance Initiatives Strengthen RSV Testing Infrastructure and Lab Capacity
    • Growth in Home Testing and Telemedicine Platforms Supports Market for Self-Administered RSV Diagnostics
    • OEM Partnerships With Clinics and Urgent Care Centers Drive Adoption of RSV Testing Solutions
    • Emphasis on Infection Control and Early Isolation Drives Utilization of Rapid RSV Screening in Emergency Departments
    • Expansion of Test Panels Including Flu, COVID-19, and RSV Enhances Value Proposition of Respiratory Syndromic Testing
    • Increased Awareness Among Pediatricians and Family Physicians Supports Broader Adoption of RSV Testing
    • Integration of Diagnostic Results With EMR Systems and Digital Health Tools Improves Case Tracking
    • Public Funding for Pediatric Infectious Disease Research Stimulates RSV Diagnostic Development
    • Growth in Long-Term Care Facility Monitoring Programs Expands Use of RSV Testing in Geriatric Populations
    • Inclusion of RSV Testing in School Health Programs Opens New Application Channels
    • Availability of FDA-Approved RSV Diagnostics Enhances Reimbursement Pathways in the U.S.
    • R&D in RSV Biomarker and Antibody Detection Technologies Drives Diagnostic Innovation
    • Global Surveillance and Vaccine Pipeline Progression Spurs Parallel Growth in Testing Infrastructure
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Respiratory Syncytial Virus Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Direct Fluorescent Antibody Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Direct Fluorescent Antibody Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Direct Fluorescent Antibody Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Rapid Antigen Diagnostic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Rapid Antigen Diagnostic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Rapid Antigen Diagnostic Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Chromatographic Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Chromatographic Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Chromatographic Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Gel Microdroplets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Gel Microdroplets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Gel Microdroplets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • JAPAN
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • CHINA
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • EUROPE
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • FRANCE
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • GERMANY
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: UK 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Spain 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Russia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Australia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • INDIA
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: India 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: South Korea 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Argentina 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Brazil 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Mexico 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Iran 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Israel 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: UAE 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030
  • AFRICA
    • Respiratory Syncytial Virus Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Respiratory Syncytial Virus Diagnostics by Product - Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Product - Percentage Breakdown of Value Sales for Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Test, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry and Others for the Years 2015, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Respiratory Syncytial Virus Diagnostics by Vertical - Laboratory, Clinics, Homecare and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Africa 15-Year Perspective for Respiratory Syncytial Virus Diagnostics by Vertical - Percentage Breakdown of Value Sales for Laboratory, Clinics, Homecare and Hospitals for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제